BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15544702)

  • 21. Early B cell factor is an activator of the B lymphoid kinase promoter in early B cell development.
    Akerblad P; Sigvardsson M
    J Immunol; 1999 Nov; 163(10):5453-61. PubMed ID: 10553071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. B-cell transcription factor expression and immunoglobulin gene rearrangement frequency in acute myeloid leukemia with t(8;21)(q22;q22).
    Johnson RC; Ma L; Cherry AM; Arber DA; George TI
    Am J Clin Pathol; 2013 Sep; 140(3):355-62. PubMed ID: 23955454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bcl-2 overexpression leads to increases in suppressor of cytokine signaling-3 expression in B cells and de novo follicular lymphoma.
    Vanasse GJ; Winn RK; Rodov S; Zieske AW; Li JT; Tupper JC; Tang J; Raines EW; Peters MA; Yeung KY; Harlan JM
    Mol Cancer Res; 2004 Nov; 2(11):620-31. PubMed ID: 15561778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aberrant expression of CD19 in AML with t(8;21) involves a poised chromatin structure and PAX5.
    Walter K; Cockerill PN; Barlow R; Clarke D; Hoogenkamp M; Follows GA; Richards SJ; Cullen MJ; Bonifer C; Tagoh H
    Oncogene; 2010 May; 29(20):2927-37. PubMed ID: 20208555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of transcription factors Pu.1, Spi-B, Blimp-1, BSAP and oct-2 in normal human plasma cells and in multiple myeloma cells.
    Nagy M; Chapuis B; Matthes T
    Br J Haematol; 2002 Feb; 116(2):429-35. PubMed ID: 11841448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction in DNA binding activity of the transcription factor Pax-5a in B lymphocytes of aged mice.
    Anspach J; Poulsen G; Kaattari I; Pollock R; Zwollo P
    J Immunol; 2001 Feb; 166(4):2617-26. PubMed ID: 11160324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EBF1 drives hallmark B cell gene expression by enabling the interaction of PAX5 with the MLL H3K4 methyltransferase complex.
    Bullerwell CE; Robichaud PP; Deprez PML; Joy AP; Wajnberg G; D'Souza D; Chacko S; Fournier S; Crapoulet N; Barnett DA; Lewis SM; Ouellette RJ
    Sci Rep; 2021 Jan; 11(1):1537. PubMed ID: 33452395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The PAX5 oncogene is expressed in N-type neuroblastoma cells and increases tumorigenicity of a S-type cell line.
    Baumann Kubetzko FB; Di Paolo C; Maag C; Meier R; Schäfer BW; Betts DR; Stahel RA; Himmelmann A
    Carcinogenesis; 2004 Oct; 25(10):1839-46. PubMed ID: 15155532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absence of T-cell- and B-cell-specific transcription factors TCF-1, GATA-3, and BSAP in Hodgkin's Reed-Sternberg cells.
    Hsu PL; Xie SS; Hsu SM
    Lab Invest; 1996 Feb; 74(2):395-405. PubMed ID: 8780159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The B29 (immunoglobulin beta-chain) gene is a genetic target for early B-cell factor.
    Akerblad P; Rosberg M; Leanderson T; Sigvardsson M
    Mol Cell Biol; 1999 Jan; 19(1):392-401. PubMed ID: 9858563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allele-specific expression patterns of interleukin-2 and Pax-5 revealed by a sensitive single-cell RT-PCR analysis.
    Rhoades KL; Singh N; Simon I; Glidden B; Cedar H; Chess A
    Curr Biol; 2000 Jun; 10(13):789-92. PubMed ID: 10898982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reversion of B cell commitment upon loss of Pax5 expression.
    Mikkola I; Heavey B; Horcher M; Busslinger M
    Science; 2002 Jul; 297(5578):110-3. PubMed ID: 12098702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stepwise reprogramming of B cells into macrophages.
    Xie H; Ye M; Feng R; Graf T
    Cell; 2004 May; 117(5):663-76. PubMed ID: 15163413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early B cell factor promotes B lymphopoiesis with reduced interleukin 7 responsiveness in the absence of E2A.
    Seet CS; Brumbaugh RL; Kee BL
    J Exp Med; 2004 Jun; 199(12):1689-700. PubMed ID: 15210745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PAX5/TEL acts as a transcriptional repressor causing down-modulation of CD19, enhances migration to CXCL12, and confers survival advantage in pre-BI cells.
    Fazio G; Palmi C; Rolink A; Biondi A; Cazzaniga G
    Cancer Res; 2008 Jan; 68(1):181-9. PubMed ID: 18172310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of B cell-associated transcription factors in B-cell precursor acute lymphoblastic leukemia cells: association with PU.1 expression, phenotype, and immunogenotype.
    Nishii K; Kita K; Miwa H; Shikami M; Taniguchi M; Usui E; Katayama N; Shiku H
    Int J Hematol; 2000 Jun; 71(4):372-8. PubMed ID: 10905058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vav-2 controls NFAT-dependent transcription in B- but not T-lymphocytes.
    Doody GM; Billadeau DD; Clayton E; Hutchings A; Berland R; McAdam S; Leibson PJ; Turner M
    EMBO J; 2000 Nov; 19(22):6173-84. PubMed ID: 11080163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The B-cell transcription factors BSAP, Oct-2, and BOB.1 and the pan-B-cell markers CD20, CD22, and CD79a are useful in the differential diagnosis of classic Hodgkin lymphoma.
    Browne P; Petrosyan K; Hernandez A; Chan JA
    Am J Clin Pathol; 2003 Nov; 120(5):767-77. PubMed ID: 14608905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IRF4 negatively regulates proliferation of germinal center B cell-derived Burkitt's lymphoma cell lines and induces differentiation toward plasma cells.
    Teng Y; Takahashi Y; Yamada M; Kurosu T; Koyama T; Miura O; Miki T
    Eur J Cell Biol; 2007 Oct; 86(10):581-9. PubMed ID: 17651861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early B-cell factor-associated zinc-finger gene is a frequent target of retroviral integration in murine B-cell lymphomas.
    Warming S; Suzuki T; Yamaguchi TP; Jenkins NA; Copeland NG
    Oncogene; 2004 Apr; 23(15):2727-31. PubMed ID: 15048087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.